Biotechnology company Momenta Pharmaceuticals has announced the issuance of a patent from the US Patent and Trademark Office to The Rockefeller University for sialylation technology. The patent expires in 2028 and covers methods of ...
Tags: Momenta, US Patent, Sialylation Technology